Burn aggravated infected wart in a patient with type 2 diabetes: a medical challenge

BMJ Case Rep. 2018 Mar 28:2018:bcr2017222897. doi: 10.1136/bcr-2017-222897.

Abstract

An infectious wart of foot in a patient with diabetics is a medical challenge, and it gets worse when aggravated with burns. We present a case of a 67-year-old Pakistani man, diabetic for 20 years presented at our healthcare centre. While awaiting his culture sensitivity report, he was prescribed an empiric antibiotic therapy. Patient then travelled to Saudi Arabia for pilgrimage 3 days later with growth of Staphylococcus aureus and Proteus species in culture and sensitivity report; during his travel, he walked barefoot and the infected wart aggravated with severe burn. Patient continued empiric treatment for 14 days. On his arrival, infected wart worsened with dead burnt skin, heavy purulent discharge on plantar region. X-rays revealed marked arthritic changes. Cefepime 500 mg three times a day intravenously was initiated following wound debridement. Patient was switched to moxifloxacin 400 mg once daily postoperatively for 7 days until completely healed.

Keywords: dermatological; diabetes; drugs: infectious diseases; infections; wound care.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Burns / complications*
  • Cefepime
  • Cephalosporins / therapeutic use
  • Diabetes Mellitus, Type 2 / complications*
  • Fluoroquinolones / therapeutic use
  • Foot
  • Foot Diseases / complications
  • Foot Diseases / drug therapy*
  • Foot Diseases / microbiology
  • Humans
  • Male
  • Moxifloxacin
  • Pakistan
  • Saudi Arabia
  • Staphylococcal Infections / complications*
  • Staphylococcal Infections / drug therapy*
  • Staphylococcus aureus / isolation & purification
  • Warts / complications*

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Fluoroquinolones
  • Cefepime
  • Moxifloxacin